Avion Wealth’s Lexicon Pharmaceuticals LXRX Stock Holding History

Avion Wealth’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Sell	1,115 -218	-16%	-$425	﹤0.01%	1086
2026 Q1	$2K	Hold	1,333	–	–	﹤0.01%	883
2025 Q4	$1K	Hold	1,333	–	–	﹤0.01%	1073
2025 Q3	$1K	Hold	1,333	–	–	﹤0.01%	1049
2025 Q2	$1K	Buy	1,333 +199	+18%	+$129	﹤0.01%	1007
2025 Q1	$0	Buy	+1,134	New	+$715	﹤0.01%	1226
2024 Q4	–	Sell	-407	Closed	–	–	1174
2024 Q3	$0	Hold	407	–	–	﹤0.01%	1206
2024 Q2	$0	Hold	407	–	–	﹤0.01%	1131
2024 Q1	$1K	Hold	407	–	–	﹤0.01%	1005
2023 Q4	$1K	Hold	407	–	–	﹤0.01%	866
2023 Q3	$0	Hold	407	–	–	﹤0.01%	1039
2023 Q2	$0	Hold	407	–	–	﹤0.01%	915
2023 Q1	$0	Hold	407	–	–	﹤0.01%	683
2022 Q4	$0	Hold	407	–	–	﹤0.01%	508
2022 Q3	$1K	Hold	407	–	–	﹤0.01%	466
2022 Q2	$1K	Hold	407	–	–	﹤0.01%	462
2022 Q1	$1K	Hold	407	–	–	﹤0.01%	370
2021 Q4	$2K	Hold	407	–	–	﹤0.01%	337
2021 Q3	$2K	Hold	407	–	–	﹤0.01%	322
2021 Q2	$2K	Hold	407	–	–	﹤0.01%	309
2021 Q1	$2K	Hold	407	–	–	﹤0.01%	302
2020 Q4	$1K	Hold	407	–	–	﹤0.01%	335
2020 Q3	$1K	Hold	407	–	–	﹤0.01%	290
2020 Q2	$1K	Hold	407	–	–	﹤0.01%	262
2020 Q1	$1K	Buy	+407	New	+$1.21K	﹤0.01%	286

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Avion Wealth's LXRX Position: Q2 2026 in Review

Avion Wealth reduced its Lexicon Pharmaceuticals (LXRX) stake by 16% in Q2 2026, selling an estimated $425 and leaving 1,115 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1086.

Avion Wealth first reported a position in LXRX in Q1 2020 and has held it in 25 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

Avion Wealth held 1,115 shares of Lexicon Pharmaceuticals worth $2K as of Q2 2026.
Avion Wealth sold 218 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $425.
Lexicon Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1086 holding.
Avion Wealth first reported a position in Lexicon Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.